维普期刊资源整合服务平台（V6.5）

723篇 您的检索式：期刊名="Drug Safety"

选中清除导出查看参考文献查看引证文献引用追踪共37页首页上一页第1页下一页末页 /37 跳转

	题名	作者	年代	出处	被引量
1	A systematic review of the safety of probiotics显示文摘	Tina Didari Sara Solki Shilan Mozaffari Shekoufeh Nikfar Mohammad Abdollahi	2014	Expert Opinion on Drug Safety2014，，2：	3
2	Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct显示文摘	Fontana Robert J Watkins Paul B Bonkovsky Herbert L Chalasani Naga Davern Timothy Serrano Jose Rochon James	2009	Drug Safety2009，，1：	2
3	Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase(TM)显示文摘	Suzuki Ayako Andrade Raul J Bjornsson Einar Lucena M Isabel Lee William M Yuen Nancy A Hunt Christine M Freston James W	2010	Drug Safety2010，，6：	2
4	Safety of Green Tea Extracts: A Systematic Review by the US Pharmacopeia显示文摘	Sarma Dandapantula N Barrett Marilyn L Chavez Mary L Gardiner Paula Ko Richard Mahady Gail B Marles Robin J Pellicore Linda S Giancaspro Gabriel I Dog Tieraona Low	2008	Drug Safety2008，，6：	2
5	Safety of long-term nucleos(t)ide treatment in chronic hepatitis B显示文摘	Ezequiel Ridruejo Marcelo O Silva	2012	Expert Opinion on Drug Safety2012，，3：	2
6	CIOMS and ICH Initiatives in Pharmacovigilance and Risk Management显示文摘	Tsintis P La Mache E	2004	Drug Safety2004，27，8：	1
7	The Art and Science of Risk Management显示文摘	Bush J	2005	Drug Safety2005，28，1：	1
8	Determina- tion of the frequency and direct cost of the adverse drug e- vents in Argentina 显示文摘	Izquierdo E Rodrfguez C Pampliega E	2010	Current drug safety2010，4，2：	1
9	Drug-induced acute pancreatitis 显示文摘	Bergholm U Langman M Rawlins M	1995	Pharmacoepidemiol Drug Safety1995，4，：	1
10	Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports显示文摘	Evans SJW Waller PC Davis S	2001	Pharmacoepidemilology and drug safety2001，10，：	1
11	Dobutamine stress echocardiography: safety in diagnosing 显示文摘	Lattanzi F Picano E Adamo E	2000	Drug Safety2000，22，：	1
12	Adverse Effects of Contrast Media Incidence,Prevention and Management显示文摘	Thomsen HS Bush WH	1998	Drug Safety1998，19，4：	1
13	Safety and tolerability of paricalcitol in pa- tients with chronic kidney disease显示文摘	Dyer Christopher A	2013	Expert Opinion on drug safety2013，12，5：	1
14	Clinical use of anti-TNF therapy and increased risk of infections显示文摘	Tauseef Ali Kaitha Bronze Stone Ftaisi Mahmood	2013	Drug Healthcare and Patient Safety (default)2013，，：	1
15	A Benefit-Risk Assessment of Ba-clofen in Severe Spinal Spasticity 显示文摘	Alessandro D Giustino Ti	2004	Drug Safety2004，27，11：	1
16	Renal failure associated with the use of celecoxib and rofecoxib 显示文摘	Kortepeter C Brinker A	2002	Drug Safety2002，25，7：	1
17	Trends in spontaneous adverse drug reaction reports to the french pharmacovigilance system (1986-2001)显示文摘	Roux E Miremont-Salam'e G	2005	Drug Safety2005，28，8：	1
18	Issues related to monitoring the safety of over-the-counter (OTC) medicines 显示文摘	Bond C Hannaford P	2003	Drug Safety2003，26，15：	1
19	Zanamivir A Review of Clinical Safety显示文摘	Freund B Gravenstein S Elliott M	1999	Drug Safety1999，21，4：	1
20	Risk and benefits of selective serotonin reuptake inhibitors in the treatment of depression显示文摘	Mourilhe P Stock PE	1998	Drug Safety1998，18，：	1

返回顶部每页显示：

共37页首页上一页第1页下一页末页 /37 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示